SEC Filing Analysis: Medpace Holdings, Inc. (MEDP)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An executive sold $10.9 million worth of stock, representing a small fraction of the company's market capitalization but a notable portion (27.5%) of their personal holdings.
• Market Impact: The transaction is unlikely to have a material impact on the stock price due to its small size relative to the company's total market value and shares outstanding.

Company Information

Field	Value
Company	Medpace Holdings, Inc.
Ticker Symbol	MEDP
CIK	0001668397
Industry	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Insider Information

Field	Value
Name	BURWIG SUSAN E
CIK	0001677418
Title/Position	Exec. VP, Operations
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-11
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	18,000
Price Per Share	$605.00
Total Value	$10,890,000
Shares Owned After	47,500
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$10,890,000
% of Market Cap	0.066%
Shares Transacted	18,000
% of Shares Outstanding	0.064%
Post-Transaction Ownership	47,500 shares (0.169% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a $16.60 billion market capitalization, this $10.9 million sale is considered routine and not material from a market perspective.
• Ownership Concentration: The sale reduced the insider's holdings by 27.5% (from 65,500 to 47,500 shares). While a significant reduction in personal holdings, her post-transaction ownership remains a very small fraction of the total shares outstanding.
• Transaction Significance: The transaction's value and share volume fall well below the thresholds for moderate or high significance (<0.1% of market cap and <0.1% of shares outstanding). Its primary relevance is as a data point on insider sentiment, which could be interpreted as profit-taking or portfolio diversification.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is too small relative to Medpace's market capitalization and daily trading volume to independently influence the stock price. It is a routine insider sale.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction size is unlikely to cause a noticeable spike in trading volume.
• Sentiment Indicator: Neutral. While a sale is technically a bearish signal, the small size relative to the company makes it non-material. It is common for executives to sell shares for personal financial planning, unrelated to company outlook.

Additional Context

Transaction Notes

• Special Circumstances: The filing notes the sale was made pursuant to a limit order placed during an open trading window, which is a standard corporate procedure for insiders.
• Market Environment: The transaction's context depends on the stock's recent performance. If following a significant run-up, it could be seen as simple profit-taking.